Experts reveal factor in rising drug costs for consumers

Read Time:6 Minute, 11 Second

OF ANOTHER PERSON COLD SPELL OVER THE
NEXT WEEK. QUIET WEEK. NEXT WEEK. PEACEFUL WEEK. A LITTLE ON THE COZY SIDE. SILENT WEEK. A LITTLE ON THE WARM SIDE.
>>> > > > PRESCRIPTION MEDICINE RATES ARE A LITTLE ON THE WARM SIDE.
>>> > > > PRESCRIPTION DRUG RATES ARE
ESCALATING IN FLORIDA. >>> > > > PRESCRIPTION DRUG COSTS ARE
INCREASING IN FLORIDA. NAME-BRAND DRUG USED TO SKYROCKETING IN FLORIDA. NAME-BRAND MEDICINE UTILIZED TO
BEAT CANCER CELLS, DIABETES MELLITUS, ASTHMA NAME-BRAND DRUG USED TO
BEAT CANCER, DIABETES, ASTHMA
AND ALSO SO LOTS OTHER PROBLEMS BEAT CANCER CELLS, DIABETES MELLITUS, ASTHMA
AND ALSO SO LOTS OF OTHER CONDITIONS
HAVE ACTUALLY INCREASED AS LONG AS 73% THEREFORE LOTS OF OTHER PROBLEMS
HAVE INCREASED AS MUCH AS 73%.
SINCE 2015.

HAVE ACTUALLY RAISED AS HIGH AS 73%.
BECAUSE 2015.
>>> > Alex: IN TODAY’S HEALTHCAST, GIVEN THAT 2015.
>>> > Alex: IN TODAY’S HEALTHCAST,.
WE CONSIDER A KEY ASPECT THAT >>> > Alex: IN TODAY’S HEALTHCAST,.
WE CONSIDER A KEY ASPECT THAT.
SPIKES AND ALSO HAS AN EFFECT IN WE CHECK OUT A SECRET FACTOR THAT.
SPIKES AND HAS AN EFFECT IN.
HAVING– MAKING SURE THAT SPIKES AND ALSO HAS AN EFFECT IN.
HAVING– MAKING CERTAIN THAT.
PEOPLE GET THE ESSENTIAL DRUGS HAVING– MAKING CERTAIN THAT.
PEOPLE OBTAIN THE VITAL MEDICINE.
THAT THEY DEMAND. PEOPLE GET THE VITAL MEDICINE.
THAT THEY NEED.
>>> > Press reporter: AS EXECUTIVE THAT THEY DEMAND.
>>> > Press reporter: AS EXECUTIVE.
SUPERVISOR OF THE NATIONAL >>> > Reporter: AS EXECUTIVE.
SUPERVISOR OF THE NATIONAL.
MULTIPLE SCLEROSIS FOUNDATION, SUPERVISOR OF THE NATIONAL.
MULTIPLE SCLEROSIS FOUNDATION,.
NATALIE BLAKE HAS SEEN INDIVIDUALS NUMEROUS SCLEROSIS FOUNDATION,.
NATALIE BLAKE HAS SEEN INDIVIDUALS.
FACE THE HIGH EXPENSE OF HANDLING NATALIE BLAKE HAS SEEN INDIVIDUALS.
FACE THE HIGH PRICE OF HANDLING.
WITH THIS DISEASE.FACE THE HIGH PRICE OF HANDLING. WITH THIS CONDITION.
> > THE STANDARD EXPENSE OF
>> THE WITH THIS ILLNESS. > > THE AVERAGE EXPENSE OF THE. CONDITION CUSTOMIZING MEDICATIONS FOR MS > > THE AVERAGE EXPENSE OF THE. CONDITION CUSTOMIZING MEDICATIONS FOR MS. IS 60,000 A YEAR.
DISEASE MODIFYING MEDICATIONS FOR MS. IS 60,000 A YEAR.
> > Kristi: INCREASE IN>>THE COST OF IS 60,000 A YEAR. > > Kristi: INCREASE IN THE
>>PRICE OF. ALL KINDS OF MEDICATION IS FEE >>> > Kristi: INCREASE IN THE PRICE OF.
ALL KINDS OF MEDICINE IS FEE.
PARTIALLY OF DRUG STORE ADVANTAGE ALL KINDS OF MEDICATION IS DUE.
IN COMPONENT OF DRUG STORE BENEFIT.
MANAGERS OR PDMs. PARTIALLY OF DRUG STORE BENEFIT.
MANAGERS OR PDMs.
>> > > DRUG STORE ADMINISTRATION MANAGERS MANAGERS OR PDMs.
>> > > PHARMACY MONITORING MANAGERS.
WERE ARCHITECTED DECADES BACK OF >> > > PHARMACY MANAGEMENT MANAGERS.
WERE ARCHITECTED DECADES EARLIER OF.
IT HELPING WITH THE CLAIMS WERE ARCHITECTED YEARS BACK OF.
IT PROMOTING THE DECLARES.
PURCHASE ON THE PHARMACY IT HELPING WITH THE DECLARES.
DEAL ON THE DRUG STORE.
RESPOND TO WITH THEIR INSURANCE TRANSACTION ON THE PHARMACY.
RESPOND TO WITH THEIR INSURANCE COVERAGE.
COMPANY.COUNTER WITH THEIR INSURANCE POLICY. COMPANY. > > Reporter: INITIALLY INTENDED COMPANY. > > Press Reporter: ORIGINALLY MEANT.
>>TO CONTROL MEDICINE COSTS AS WELL AS > > Press Reporter: INITIALLY MEANT. TO >>CONTROL MEDICATION PRICES AS WELL AS.
OBTAINABLE.
TO CONTROL MEDICINE EXPENSES AS WELL AS.
OBTAINABLE. PRICES PROFESSIONALS CLAIM THESE CENTER ACCESSIBLE. PRICING EXPERTS STATE THESE CENTER.
MALES BETWEEN MEDICINE SUPPLIERS VALUING EXPERTS SAY THESE CENTER.
MEN BETWEEN MEDICINE PRODUCERS.
AND INSURANCE COMPANIES ARE MALE BETWEEN DRUG MANUFACTURERS.
AND ALSO INSURANCE COMPANIES ARE.
INCREASING THE COST OF AND ALSO INSURANCE PROVIDER ARE.
INCREASING THE COST OF.
PRESCRIPTION DRUGS. INCREASING THE PRICES OF.
PRESCRIPTION MEDICINES.
>> > > PBM WERE PAID BY MEDICATION PRESCRIPTION DRUGS.
>> > > PBM WERE PAID BY DRUG.
PRODUCERS.

>> > > PBM WERE PAID BY DRUG.
MAKERS. STARTED OPENING THEIR OWN MANUFACTURERS. BEGAN OPENING THEIR OWN.
PHARMACIES. BEGAN OPENING THEIR OWN.
PHARMACIES. RATHER THAN WORKING TO CONTROL PHARMACIES. AS OPPOSED TO FUNCTIONING TO CONTROL.
THE COST OF THE TRANSACTION, INSTEAD OF WORKING TO CONTROL.
THE COST OF THE PURCHASE,.
BEGAN PROFITING OFF OF THE THE PRICE OF THE PURCHASE,.
BEGAN PROFITING OFF OF THE.
DEAL. BEGAN PROFITING OFF OF THE.
PURCHASE.
>> > > BASE ON SAT AFIRED, PURCHASE.
>> > > ACCORDING TO SAT AFIRED,.
THREE PBMs IF CONTROL 80% OF THE >> > > ACCORDING TO SAT AFIRED,.
THREE PBMs IF CONTROL 80% OF THE.
MEDICATION TRANSACTIONS. 3 PBMs IF CONTROL 80% OF THE.
DRUG TRANSACTIONS. WHILE THESE PBMs. MEDICATION PURCHASES. WHILE THESE PBMs.
$ 82 BILLION. WHILE THESE PBMs.
$ 82 BILLION. THEY SHOW 2% OF THOSE REBATES $82 BILLION. THEY SHOW 2% OF THOSE REBATES.
WERE PASSED ON TO THE CUSTOMER THEY PROGRAM 2% OF THOSE REBATES.
WERE PASSED ON TO THE CONSUMER.
IN THE KIND OF LOWER PRICE.WERE PASSED

ON TO THE CUSTOMER.
IN THE KINDS OF LOWER PRICE. BLAKE, THAT HERSELF SUFFERS FROM IN THE TYPES OF LOWER PRICE. BLAKE, WHO HERSELF SUFFERS FROM.
BRONCHIAL ASTHMA, States PBMs PROVIDE ACCESS BLAKE, WHO HERSELF SUFFERS FROM.
BRONCHIAL ASTHMA, Claims PBMs Offer ACCESSIBILITY.
TO MEDICINE. ASTHMA, SAYS PBMs Supply ACCESSIBILITY.
TO MEDICINE.
>> > > I WAS ON A DRUG FOR FIVE TO DRUG.
>> > > I WAS ON A MEDICATION FOR 5.
YEARS. >> > > I WAS ON A MEDICINE FOR FIVE.
YEARS. I OBTAIN THERE, AND THEY SAYS IT YEARS. I OBTAIN THERE, AND THEY SAYS IT.
NOT AUTHORIZED. I OBTAIN THERE, AND THEY SAYS IT.
NOT AUTHORIZED.
>> > > A PRESS IS ON TO SEE HOW THE NOT AUTHORIZED.
>> > > A PRESS IS ON TO SEE HOW THE.
SYSTEM OPERATES. >> > > A PUSH IS ON TO SEE HOW THE.
SYSTEM RUNS.
>> > > WE REQUIREMENT TO RECALIBRATE AND ALSO SYSTEM OPERATES.
>> > > WE DEMAND TO RECTIFY AND ALSO.
THEY NO LONGER PROFIT OFF OF THE >> > > WE DEMAND TO RECTIFY AS WELL AS.
THEY NO MORE EARNINGS OFF OF THE.
INCREASING PRICES OF DRUG THEY NO MORE EARNINGS OFF OF THE.
CLIMBING EXPENSES OF DRUG.
AND WHEN THEY SUCCESSFULLY LOWER RISING EXPENSE OF DRUG.
AS WELL AS WHEN THEY EFFICIENTLY LOWER.
THAT PRICES OF MEDICATION AND ALSO PASS AND WHEN THEY SUCCESSFULLY REDUCED.
THAT PRICES OF MEDICINE AS WELL AS PASS.
THOSE FINANCIAL SAVINGS ON CONSUMERS.THAT COST OF DRUG AND ALSO PASS. THOSE COST SAVINGS ON TO CUSTOMERS. > > Kristi: THE MS FOUNDATION AS THOSE>>SAVINGS ON TO CUSTOMERS. > > Kristi: THE MS FOUNDATION AS>. WELL AS OTHER GROUPS HAVE CALLED
> > Kristi: THE MS STRUCTURE AS. WELL AS >>OTHER GROUPS HAVE ACTUALLY CALLED.
ON THE FEDERAL PROFESSION PAYMENT WELL AS OTHER GROUPS HAVE CALLED. ON THE FEDERAL PROFESSION COMPENSATION. TO INVESTIGATE THE EFFECT ON THE FEDERAL PROFESSION COMMISSION. TO INVESTIGATE THE EFFECT.
THESE PBMs HAVE ON MILLIONS OF TO CHECK OUT THE INFLUENCE. THESE PBMs HAVE ON MANY MILLIONS OF.
AMERICANS TO ENHANCE PATIENT THESE
PBMs Carry NUMEROUS. AMERICANS TO IMPROVE INDIVIDUAL.
ACCESSIBILITIES AND COST TO.